A federal jury decided Wednesday that Monsanto was paying more than $ 80 million in damages to a California man whose cancer was partly caused by the use of the popular Weedkiller Roundup.
The six-member jury found that Monsanto should do this for the man's illness because he did not have a label attached to his product indicating the cancer risk of the Weedkiller.
The ruling in San Francisco's United States District Court marks a milestone in the ongoing public debate on the health effects of Roundup and its active ingredient, glyphosate, the most commonly used weedkiller in the world. Monsanto is currently defending itself against thousands of similar allegations.
The verdict of Wednesday ended the second of two phases of the study. Last week, the jury made its first verdict, saying that the weed control was a "major factor" in the development of Mr. Hardeman's cancer. The jury then began on Tuesday afternoon to consider whether Monsanto should prove negligence and be held liable.
In determining the responsibility of Monsanto, the jury granted Mr. Hardeman $ 75 million in punitive damages, one of his lawyers, Jennifer Moore, said in a telephone interview. Approximately $ 5 million was also spent on Mr. Hardeman's past and future woes and over $ 200,000 on medical bills, Ms. Moore said.
Moore said Monsanto has consistently ignored scientific studies on the unhealthy effects of Roundup.
"The evidence is overwhelming that Roundup can cause non-Hodgkin's lymphoma," she said. "And yet Monsanto continues to deny that." She said that Mr. Hardeman's cancer was in remission.
A statement from Bayer, which acquired Monsanto last year, said the company would contest the jury's verdict.
"We are disappointed with the jury's decision, but this ruling does not change the weight of more than four decades of science and the conclusions of regulators worldwide who support the safety of our glyphosate-based herbicides and are not carcinogenic." Opinion
In December 2017, the Environmental Protection Agency published a draft for a human health risk assessment in which glyphosate was unlikely to be carcinogenic to humans.
During the trial, Mr. Hardeman's legal team provided expert opinion Roundup causes mutations in human cells, and people exposed to Roundup are more likely to develop non-Hodgkin's lymphoma.
Bayer's sta He said that the jury felt that the jury was most likely split on the scientific evidence in the case, suggesting that the jurors needed more than four days to discuss the issue Judgment of the last week to decide.
A similar case was decided Last year, a Californian jury found that Monsanto had failed to warn a landowner of the school of Roundup's cancer risks. The jury ordered Monsanto to pay $ 289 million in damages. Later, a judge reduced this payment to about $ 80 million. Monsanto also appeals against this verdict.
"Now, two different juries have found Roundup to cause a person's non-Hodgkin's lymphoma," Ms. Moore said, "and Monsanto should be punished for his behavior."